Details for New Drug Application (NDA): 210218
✉ Email this page to a colleague
The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 210218
Tradename: | DESMOPRESSIN ACETATE |
Applicant: | Ubi |
Ingredient: | desmopressin acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 210218
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 210218 | ANDA | Dr.Reddys' Laboratories Inc | 43598-931 | 43598-931-09 | 10 AMPULE in 1 BOX (43598-931-09) / 1 mL in 1 AMPULE |
DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 210218 | ANDA | UBI Pharma Inc. | 72843-459 | 72843-459-10 | 10 AMPULE in 1 BOX (72843-459-10) / 1 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.004MG/ML | ||||
Approval Date: | Feb 14, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription